title: TlpTLE: epotin and pure red-cell aplasia: what do we have?
authors.forename: Gai
authors.initials: G
authors.lastname: Massimo
authors.forename: Motta
authors.initials: M
authors.lastname: Daria
authors.forename: Piccoli B
authors.initials: PB
authors.lastname: Giorgina
authors.forename: Jeantet
authors.initials: J
authors.lastname: Alberto
mesh_terms: D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D006397:Hematinics / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy* / Q000209:etiology
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa